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Deletion of scavenger receptor A protects mice from
progressive nephropathy independent of lipid
control during diet-induced hyperlipidemia
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Farhad R. Danesh2
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Scavenger receptor A (SR-A) is a key transmembrane receptor
in the endocytosis of lipids and contributes to the
pathogenesis of atherosclerosis. To assess its role in
hyperlipidemic chronic kidney disease, wild-type and SR-A-
deficient (knockout) mice underwent uninephrectomy
followed by either normal or high-fat diet. After 16 weeks of
diet intervention, hyperlipidemic wild-type mice presented
characteristic features of progressive nephropathy:
albuminuria, renal fibrosis, and overexpression of
transforming growth factor (TGF)-b1/Smad. These changes
were markedly diminished in hyperlipidemic knockout mice
and attributed to reduced renal lipid retention, oxidative
stress, and CD11cþ cell infiltration. In vitro, overexpression of
SR-A augmented monocyte chemoattractant protein-1
release and TGF-b1/Smad activation in HK-2 cells exposed to
oxidized low-density lipoprotein. SR-A knockdown prevented
lipid-induced cell injury. Moreover, wild-type to knockout
bone marrow transplantation resulted in renal fibrosis in
uninephrectomized mice following 16 weeks of the high-fat
diet. In contrast, knockout to wild-type bone marrow
transplantation led to markedly reduced albuminuria,
CD11cþ cell infiltration, and renal fibrosis compared to wild-
type to SR-A knockout or wild-type to wild-type bone
marrow transplanted mice, without difference in plasma lipid
levels. Thus, SR-A on circulating leukocytes rather than
resident renal cells predominantly mediates lipid-induced
kidney injury.
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Evidence has been increasingly provided that lipid accumula-
tion in kidney contributes to the progression of chronic
kidney disease (CKD).1,2 Receptor-mediated lipid uptake is
the crucial step for lipid retention in the kidney, while this is
also caused by impaired cholesterol synthesis and inhibited
cholesterol efflux via adenosine triphosphate-binding cassette
transporter 1.3–9 Several lines of data have indicated that the
specific transmembrane receptors, including scavenger re-
ceptor A (SR-A), CD36, lectin-like oxidized low-density
lipoprotein receptor-1, and C-X-C motif ligand 16, recognize
oxidative low-density lipoprotein (ox-LDL) based on ather-
ogenesis data.5–9 Among these receptors, SR-A has been
identified on macrophages, endothelial cells, renal mesangial
cells, smooth muscle cells, dendritic cells, and renal tubular
epithelial cells.6,10–13 Unlike other lipoprotein receptors,
SR-A is not regulated via negative feedback by cytoplasmic
cholesterol, and hence plays a key role in the formation of
foam cells.12,14
Previous studies have shown that deletion of SR-A
decreased aortic wall plaque formation in mice fed with
high-fat diet and had no impact on the plasma lipid
level.5,11,13 SR-A mediates endocytosis of ox-LDL, and
activates intracellular signaling pathways that contribute to
the atherosclerosis. Its mechanistic role in atherosclerosis
elicited by hyperlipidemia may suggest possible mechanisms
underlying the development of lipid-induced renal injury
and enhance the design of novel therapeutic strategies against
the progression of CKD. However, the effect of SR-A
deficiency on the progressive CKD of hyperlipidemia and
the underlying mechanism by which SR-A modulates renal
fibrosis remains poorly understood.
Here, we use SR-A deficient (SR-A/) mice to test the
hypothesis that its deficiency will protect kidney from lipid
nephrotoxicity in progressive renal fibrosis. We identified
SR-A as a key regulator in the renal lipid retention, CD11cþ
cell recruitment, and oxidative stress in uninephrectomized
mice following 16 weeks of high-fat diet. Using genetic
approaches, we validated SR-A as a critical modulator of
transforming growth factor (TGF)-b1/Smad signaling and
monocyte chemoattractant protein-1 (MCP-1) in HK-2 cells
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exposed to ox-LDL in vitro. In bone marrow (BM) chimeric
mice, SR-A/ to wild-type (WT) bone marrow transplanta-
tion (BMT) led to reduced albuminuria, renal CD11cþ cell
filtration, and kidney fibrosis independent of plasma lipid
control.
RESULTS
SR-A deficiency ameliorated albuminuria and renal fibrosis in
uninephrectomized mice fed with high-fat diet
All SR-A/ mice were verified by Southern blot, western
blot, and immunohistochemistry (Supplementary Figure
S1a–c online). No significant abnormalities in body weight,
morphology, renal histology, and plasma biochemical para-
meters were found as long as 24 weeks of age between WT
and SR-A/ mice (Figure 1c and e and Table 1). To evaluate
the effect of SR-A on the hyperlipidemic renal disease, WT
and SR-A/ mice at 8 weeks of age underwent unine-
phrectomy, followed by either normal or high-fat diet for 16
weeks, following the way as described.15 Both WTand SR-A/
mice that consumed high-fat diet showed markedly increased
body weights and systemic lipid levels when compared with
normal-diet mice (Table 1). There was no difference in
plasma lipids between WT and SR-A/ mice in the
conditions of either normal or high-fat diet, indicating that
SR-A did not affect the systemic lipid levels.
Consistent with the previous studies,1,2,16 our data showed
that WTmice consuming high-fat diet developed progressive
albuminuria; however, this was lower at 8 weeks, and
significantly reduced at 16 weeks of dietary intervention in
SR-A/ mice (Figure 1a). In addition, high-fat diet resulted
in markedly reduced kidney weight/body weight in WT
mice but was mild in SR-A/ mice (Figure 1b). Normal-diet
WT and SR-A/ mice did not show remarkably increased
albuminuria (Figure 1a). Morphologically, diet-induced
hyperlipidemia caused significant glomerular mesangial
matrix accumulation and tubulointerstitial fibrosis, but no
remarkable microvascular damage in kidney was observed
under light microscope. In contrast, SR-A deficiency
substantially reduced glomerular mesangial matrix index
and tubulointerstitium fibrotic area compared with those of
WT mice with hyperlipidemia (Figure 1c–f). In addition,
persistent hyperlipidemia markedly increased the renal
deposition of fibronectin, collagen I, and collagen III in
WT mice but was mild in SR-A/ mice (Figure 2a–d).
Importantly, the improved renal outcome in SR-A/ mice
was determined to be independent of hyperlipidemia, as diet-
induced high plasma levels of cholesterol and triglyceride
were similar in both mice genotypes (Table 1).
SR-A deficiency reduced renal lipid accumulation and
oxidative stress in uninephrectomized mice fed
with high-fat diet
Using Oil Red O staining, we detected increased lipids
retention in the kidneys of high-fat diet mice. SR-A deficiency
markedly reduced the renal lipid deposition compared with
WT mice consuming high-fat diet (Figure 3a and b),
indicating that the ameliorated kidney fibrosis in SR-A/
mice was correlated with lower renal lipid deposition.
Although the initial events involved in lipid-mediated renal
damage are unclear, oxidative stress is thought to be
especially important.2,17 We revealed that mice consuming
high-fat diet showed a threefold increase in renal reactive
oxidative species (ROS), which was reduced in SR-A/ mice
(Figure 3c and d). To link the decreased ROS production to
lower lipid deposition in the kidneys, renal ROS and the
cholesterol content were quantified in the mice described
above. Our data showed that the mice with higher renal
cholesterol content correlated with higher ROS production in
the kidneys; in SR-A/ mice, renal ROS decreased with
lower content of cholesterol (Figure 3e). Also, mice consum-
ing high-fat diet showed a 3.5-fold increase in renal
malondialdehyde, a biomarker for oxidative stress,18 which
was significantly reduced in SR-A/ mice (Figure 3f). Thus,
these data suggested that SR-A deficiency decreased renal
cholesterol deposition and, consequently, reduced oxidative
stress in lipid-induced kidney injury.
SR-A deficiency decreased renal CD11cþ cell filtration
and inflammation in uninephrectomized mice fed with
high-fat diet
One detrimental effect of oxidative stress is to cause
inflammation in the progressive kidney disease.2,4,8 To test
the effect of SR-A deficiency on inflammatory profile in
response to hyperlipidemia, mice plasma inflammatory
markers were examined. There was a twofold increase in
plasma tumor necrosis factor (TNF)-a and a fourfold
increase in interleukin (IL)-6 in WT mice consuming high-
fat diet compared with those of normal diet; in contrast, SR-
A deficiency markedly reduced plasma levels of TNF-a and
IL-6 (Table 1).
Recent data showed that a specific subset of CD11cþ cells
are targets for free fatty acid–mediated increases in expression
of proinflammatory cytokine.19 We revealed that mice
consuming high-fat diet showed significantly increased
CD11cþ cells number in glomeruli and tubulointerstitium,
which was substantially reduced in SR-A/mice (Figure 4a).
Using a flow cytometric analysis, we further found that both
CD11cþ /CD68þ and CD11c/CD68þ cells increased in the
kidneys of mice fed with high-fat diet; however, SR-A/
mice showed 60% reduction of CD11cþ /CD68þ and 39.3%
reduction of CD11c/CD68þ cells compared with that of
WT mice (Figure 4b). The difference in the reduced levels of
the two subtype cells in ameliorated kidney implicated that
CD11cþ macrophages are more important than resident
macrophages in lipid-induced kidney injury. In addition, SR-
A deficiency markedly reduced TNF-a and IL-6 levels in
kidneys compared with that of WTmice in groups of high-fat
diet (Figure 4c–e).
Several lines of study demonstrated that MCP-1 is a key
mediator for inflammation.20–22 Our data showed that WT
mice consuming high-fat diet exhibited substantially in-
creased MCP-1 in plasma and kidney, and this increase was
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suppressed in SR-A/ mice (Table 1 and Figure 4c). To
better understand the effect of SR-A on MCP-1 expression in
high-fat diet mice, HK-2 cells, an immortalized proximal
tubular epithelial cell line, were incubated with ox-LDL after
forced expression or knockdown of SR-A. Consistent with
these findings in vivo, forced expression of SR-A increased the
lipids retention in HK-2 cells, and augmented the ox-LDL-
stimulated ROS generation and MCP-1 expression; in
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Figure 1 |Albuminuria and renal histology in uninephrectomized mice at 16 weeks of dietary intervention. (a) Urinary albumin/
creatinine tested at time points indicated. (b) Kidney weight, normalized for body weight. (c) Representative histological photomicrograph
of glomeruli by periodic acid–Schiff staining. Scale bar¼ 19mm. (d) Bar graph summarizing the mesangial matrix index. (e) Representative
histological photomicrograph of kidney by Masson’s trichrome staining. Scale bar¼ 19 mm. (f) Bar graph summarizing the percentage of
tubulointerstitial fibrosis area. Each bar represented the mean±s.e.m., n¼ 6–12 each group. SR-A, scavenger receptor A; SR-Aþ /þ , SR-A
wild-type mice; SR-A/, SR-A deficiency mice.
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contrast, knockdown of SR-A protected HK-2 cells from ox-
LDL-stress (Figure 5a–e). To verify that the increased
expression of MCP-1 was caused by ox-LDL-induced ROS,
we examined MCP-1 in supernatant of cultured HK-2 cells
pretreated with antioxidant manganese superoxide dismutase
(MnSOD). Our data clearly showed that inhibition of
ox-LDL-stimulated ROS markedly decreased the MCP-1
production in the condition of either normal or over-
expression of SR-A (Figure 5e).
SR-A modulated TGF-b1/Smad signaling in tubular cells
exposed to ox-LDL
Previous evidence has demonstrated a link between
inflammatory environment and activation of TGF-b1/Smad
Table 1 |Metabolic data of four groups at 16 weeks of experiment
Normal diet High-fat diet
Groups WT SR-A/ WT SR-A/
Body weight (g) 34.6±1.5 35.2±1.6 55.2±1.8a 54.5±1.7
BP (mmHg) 92.0±11.2 91.1±8.9 94.2±10.3 93.2±10.7
Plasma Cr (mmol/l) 67.5±4.3 66.2±4.8 106.0±7.8a 82.4±6.5b
Plasma triglyceride (mmol/l) 1.31±0.31 1.24±0.44 2.58±0.53a 2.45±0.46
Plasma cholesterol (mmol/l) 2.35±0.43 2.42±0.36 6.73±0.62a 6.36±0.53
Plasma MCP-1 (mg/l) 125.1±6.7 127.0±10.3 294.0±11.2a 144.0±10.2b
Plasma IL-6 (mg/l) 109.43±6.3 111.28±9.5 445.3±15.6a 169.4±8.7b
Plasma TNF-a (mg/l) 69.50±4.8 69.20±4.5 144.6±10.9a 99.9±6.4b
Abbreviations: BP, blood pressure; Cr, creatinine; IL-6, interleukin-6; MCP-1, monocyte chemoattractant protein-1; SR-A, scavenger receptor A; SR-A/, SR-A deficiency mice;
TNF-a, tumor necrosis factor-a; WT, SR-A wild-type mice.
aPo0.05 versus WT mice fed with normal diet.
bPo0.05 versus WT mice fed high-fat diet.
Data are means±s.e.m.; n=12 in each group.
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Figure 2 |Renal extracellular matrix deposition in uninephrectomized mice at 16 weeks of dietary intervention. (a) Representative
western blot analyses of fibronectin, collagen I, and collagen III in whole kidney lysate. Densitometric analysis of (b) fibronectin, (c) collagen
I, and (d) collagen III in western blot. Each bar represented the mean±s.e.m., n¼ 3 each group. b-Actin was used as loading control. SR-A,
scavenger receptor A; SR-Aþ /þ , SR-A wild-type mice; SR-A/, SR-A deficiency mice.
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Figure 3 |Renal lipid accumulation and oxidative stress in uninephrectomized mice at 16 weeks of dietary intervention.
(a) Representative Oil Red O staining in the kidneys. Red, Oil Red O–positive cells; blue, hematoxylin counterstaining. Scale bar¼ 19mm.
(b) Bar graph summarizing Oil Red–positive cells in the kidney. (c) Representative photomicrograph of super oxidative anion assessed
by staining of dihydroethidium in the kidney. Scale bar¼ 19mm. (d) Bar graph summarizing dihydroethidium intensity in the kidney.
(e) Correlation between dihydroethidium intensity and the renal cholesterol content in the kidney, n¼ 24, r¼ 0.9261, 95% confidence
interval (CI) 0.8344–0.9679, Po0.01. (f) Malondialdehyde level in the kidney of mice at 16 weeks of experiment. Each bar represented the
mean±s.e.m., n¼ 6 each group. SR-A, scavenger receptor A; SR-Aþ /þ , SR-A wild-type mice; SR-A/, SR-A deficiency mice.
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signaling that contributes to pathological decline.23–26 The
current study showed that renal TGF-b1 was markedly increased
in WTmice but was mild in SR-A/mice fed with high-fat diet
(Figure 6a and b). Upregulated TGF-b1 was confined largely to
the area where fibrosis was evident. Coincident with the
increased presence of TGF-b1, the percentage of phosphorylated
Smad2/3 (p-Smad2/3)–positive nuclei was markedly increased
in the kidneys of WTmice at 16 weeks of high-fat diet, and this
increase was substantially reduced in SR-A/ mice (Figure 6c
and d). These data demonstrated that ameliorated renal fibrosis
in hyperlipidemic SR-A/ mice related to the inhibited renal
TGF-b1/Smad signaling.
To further address that the renoprotective effect of SR-A
deficiency is associated with the inhibited TGF-b1/Smad
signaling, we stimulated HK-2 cells with ox-LDL after forced
expression or knockdown of SR-A. As shown in Figure 7a–d,
forced expressing SR-A enhanced TGF-b1 expression and
Smad2/3 activation. Conversely, knockdown of SR-A inhibi-
ted TGF-b1 expression and Smad2/3 activation in HK-2 cells
exposed to ox-LDL.
BM-derived leukocytes from SR-A/ mice decreased
albuminuria and renal fibrosis in uninephrectomized
mice fed with high-fat diet
To determine the contribution of SR-A from BM-derived
leukocytes to lipid-induced kidney injury, we performed
reciprocal BMT between WT and SR-A/ mice, using both
as donors and recipients of BMT. Neither SR-A deficiency nor
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Figure 4 | Filtration of CD11cþ cells and the proinflammatory markers in the kidney of uninephrectomized mice at 16 weeks of
dietary intervention. (a) Representative immunofluorescent staining of CD11c-positive cells in the kidney. Red, CD11cþ cells; blue, 4,6-
diamidino-2-phenylindole (DAPI)-stained nuclei; scale bar¼ 19mm; G, glomeruli. (b) Representative flow cytometry analysis of CD11cþ ,
CD68þ , and CD11cþ /CD68þ cells in the kidneys. The number in each field represented the mean percentage of the cell number from at
least three independent experiments. FITC, fluorescein isothiocyanate. (c) Renal cytosolic MCP-1, (d) TNF-a, and (e) IL-6 assayed by enzyme-
linked immunosorbent assay. Each bar represented the mean±s.e.m. for three independent experiments. IL-6, interleukin-6; MCP-1,
monocyte chemoattractant protein-1; SR-A, scavenger receptor A; SR-Aþ /þ , SR-A wild-type mice; SR-A/, SR-A deficiency mice; TNF-a,
tumor necrosis factor-a.
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BMT affected the total number of peripheral blood
erythrocyte and leukocyte counts or leukocyte differential
(Table 2). All mice that did not receive BMT died within 3
weeks of the transplant. At 4 weeks after BMT, peripheral
blood counts returned to normal and the mice underwent
uninephrectomy, and were then randomized to either normal
or high-fat diet for 16 weeks. Circulating leukocytes isolated
from WT to WT and WT to SR-A/ BMT mice showed
similar levels of SR-A expression compared with those of
leukocytes from untransplanted WTmice, indicating success-
ful BM replenishment (Figure 8a). Interestingly, SR-A/ to
WT BMT mice showed less albumin/creatinine ratio and
decreased glomerular mesangial matrix index and tubuloin-
terstitial fibrosis area compared with those of WT to WT or
WT to SR-A/ BMT mice (Figure 8b–e). Indeed, albumin/
creatinine ratio, mesangial matrix index, and tubulointer-
stitial fibrosis area in WT to SR-A/ BMT mice were
comparable to those of WT to WT BMT mice.
The role of BM-derived leukocyte SR-A in lipid-induced
kidney injury was further evaluated at 16 weeks of high-fat
diet in BMTmice. Renal content of cholesterol within kidney
was markedly reduced in SR-A/ to WT BMT mice
compared with that of WT to WT or WT to SR-A/ mice.
Interestingly, the percentage of renal CD11cþ cells and CD68
macrophages in SR-A/ to WT BMTmice was substantially
less than those of WT to WT or WT to SR-A/ BMT mice
(Figure 9b and c). In addition, there were less MCP-1,
TNF-a, and IL-6 expressed in kidney and that in plasma of
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Figure 5 | Effects of SR-A on lipid uptake, oxidative stress, and MCP-1 expression in HK-2 cells exposed to ox-LDL. (a) Representative
Oil Red O staining of HK-2 cells incubated with ox-LDL (10 mmol/l). Red, Oil Red O–positive cells; blue, 4,6-diamidino-2-phenylindole (DAPI)
counterstaining; scale bar¼ 1 mm. (b) Bar graph summarizing the percentage of Oil Red O–positive cells (300 cells were counted in three
independent experiments). (c) Representative cellular image of ROS stained by dihydrorhodamine-123 in HK-2 cells at 24 h after incubation
with ox-LDL (10mmol/l). Scale bar¼ 1mm. (d) Bar graph summarizing ROS in HK-2 cells. Each bar represented the mean±s.e.m. for three
independent experiments. (e) MCP-1 levels in the supernatant analyzed by enzyme-linked immunosorbent assay. Each bar represented the
mean±s.e.m. for three independent experiments. MCP-1, monocyte chemoattractant protein-1; MnSOD, manganese superoxide dismutase;
ox-LDL, oxidative low-density lipoprotein; ROS, reactive oxygen species; si, small interfering; SR-A, scavenger receptor A.
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SR-A/ to WT BMT mice compared with those of WT to
SR-A/ or WT to WT BMTmice (Figure 9d–f and Table 3).
These findings indicate that SR-A in circulating leukocytes
rather than in renal resident cells is the predominant
mediator in lipid-induced kidney injury.
DISCUSSION
An emerging body of evidence suggests that hyperlipidemia is
not only a risk factor for CKD progression, but also an
independent inducer for renal dysfunction.1,2 We now
document in this study the profibrotic effects of SR-A on
progressive renal fibrosis elicited by hyperlipidemia in vivo
and in vitro. Our results indicate that SR-A is a key molecule
to modulate the oxidative stress, inflammation, and fibrosis
in the pathogenesis of hyperlipidemic CKD. Our finding
suggests that SR-A deficiency protects mice from progressive
nephropathy of hyperlipidemia through inhibiting of
CD11cþ cell recruitment and TGF-b1/Smad pathway.
Importantly, we validate the effectiveness of in vivo
reconstitution with SR-A/ mice BM-derived leukocytes in
lipid-induced nephropathy.
There is increasing evidence that ROS and other reactive
species are directly involved in redox signaling pathways that
promote inflammation. Our integrated in vivo and in vitro
experimental design identified SR-A as a key modulator for
tubular cells to uptake lipid. Consistent with previous
studies,8,18,27,28 our finding revealed that SR-A modulated
ox-LDL-induced ROS generation in tubular cells, conse-
quently stimulated the expression of MCP-1, which is a key
mediator to recruit or activate inflammatory cells, and was
also important in generating proinflammatory cytokine.20–22
Another major finding of this study is that CD11cþ
cell–specific SR-A is a primary inducer of renal injury in
progressive nephropathy of hyperlipidemia. Emerging bodies
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of evidence have demonstrated a close association between
the intensity of inflammation and the severity of renal
fibrosis.8,14,29,30 Indeed, the interstitial macrophages correlate
closely with fibrosis.6,15,31,32 Macrophages are phenotypically
and functionally heterogeneous, potentially able to promote
inflammation and fibrosis or to prevent it via scavenging
activities.10,30 Recently, a specific subset of CD11cþ macro-
phages was shown to be recruited to obese adipose and
muscle tissue, and produced high levels of proinflammatory
cytokines that were linked to the tissue injury. CD11cþ cell
ablation led to a marked decrease in inflammatory markers
locally and systemically.19 Indeed, our data clearly showed
that SR-A/ mice fed with high-fat diet demonstrated
marked decrease in CD11cþ cells filtration and inflamma-
tory markers expression in both kidneys and plasma. In
chimeric study, SR-A/ to WT BMT led to reduced renal
CD11cþ as well as CD68þ cells filtration, inflammatory
cytokines expression, albuminuria, and renal fibrosis at 16
weeks of high-fat diet compared with those of WT to WT or
WT to SR-A/ BMTmice. These findings indicate that SR-A
on circulating leukocytes, such as CD11cþ , rather than on
resident cells is the predominant mediator of lipid-induced
kidney injury. Although the markedly increased MCP-1 may
be the key molecule to recruit CD11cþ in kidney, the precise
mechanism by which SR-A modulates CD11cþ function is
necessary to determine in the future study.
In addition to the oxidative stress and inflammatory
profile, we revealed that SR-A modulates TGF-b1/Smad
signaling. A wide array of studies has established that TGF-b1
modulates renal fibrosis through its downstream Smad
signaling.23,33,34 Indeed, our finding showed that deletion
of SR-A significantly inhibited TGF-b1expression and there-
by diminished phosphorylated Smad2/3 in the fibrotic
kidneys. Furthermore, the current study provided the first
evidence that forced expression of SR-A directly activates
TGF-b1/Smad signaling in HK-2 cells exposed to ox-LDL
in vitro. Therefore, inhibition of TGF-b1/Smad pathway in
uninephrectomized SR-A/ mice with hyperlipidemia may
be a mechanism whereby SR-A promotes renal fibrosis. These
findings implicate that SR-A/TGF-b1/Smad pathway is a
novel target in the treatment of renal fibrosis on hyperlipi-
demic mice model.
Taken together, our data allow us to establish that SR-A
in tubular epithelial cells initiates lipid-induced oxidative
stress and MCP-1 release, which leads to more circulating
leukocytes recruited and promotes the renal fibrosis.
Importantly, SR-A on circulating leukocytes rather than
renal resident cells predominantly mediates lipid-induced
kidney injury. These findings provide new insights into the
role of SR-A in hyperlipidemic kidney injury and open a
window of opportunity for a novel therapeutic intervention
for the progression of CKD.
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Figure 7 | Effect of SR-A on TGF-b1/Smad signaling in HK-2
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cells incubated with ox-LDL (10 mmol/l) for 24 h. Densitometric
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Table 2 | Peripheral blood counts on erythrocyte and leukocyte in mice at 4 weeks of BMT
Non-BMT mice BMT mice
Groups WT (n=12) SR-A/ (n=12) WT to WT (n=12) WT to SR-A/ (n=12) SR-A/ to WT (n=12)
RBC number ( 104/mm3) 1115±73.5 1126±96.6 1184±110.8 1152±100.3 1239±121.4
Leukocyte number ( 102/mm3) 21±2.01 20±2.14 21±1.47 20±1.68 22±1.97
Lymphocyte (%) 86.5±4.91 86.2±6.13 85.6±5.23 87.5±7.06 87.1±4.64
Monocyte (%) 3.4±0.38 3.5±0.26 4.0±0.25 3.5±0.65 4.1±0.32
Neutrophil (%) 9.4±0.65 9.5±1.12 9.7±0.95 9.8±1.64 9.8±1.79
Abbreviations: BMT, bone marrow transplantation; RBC, red blood cell number; SR-A, scavenger receptor A; SR-A/, SR-A deficiency mice; WT, SR-A wild-type mice.
Data are means±s.e.m.
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MATERIALS AND METHODS
Antibodies, plasmids, and other reagents
The antibodies and their sources are as follows: monoclonal anti-
mouse CD11c and polyclonal anti-mouse SR-A were from BD
Biosciences (Bedford, MA); monoclonal anti-mouse fibronectin,
collagen I and III, TGF-b1, and polyclonal anti-mouse phosphoser-
ine Smad2/3 and Smad2 were from Santa Cruz (Santa Cruz, CA);
monoclonal anti-mouse b-actin was from Sigma-Aldrich (Buchs SG,
Switzerland); and monoclonal anti-human TGF-b1, polyclonal anti-
human phosphoserine Smad2/3, Smad2, SR-A, and monoclonal
anti-mouse CD68 were from Abcam (Cambridge, MA).
SR-A small interfering RNA (siRNA; sc-44116) and nonspecific
siRNA was purchased from Santa Cruz. pNVL3-MnSOD plasmid35
was a kind gift from Dr Yewei Ma (Baylor College of Medicine,
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Figure 8 |Albuminuria and renal histology in BMT uninephrectomized mice at 16 weeks of dietary intervention. (a) Representative
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Houston, TX). The 30-untranslated region of the Homo sapiens
macrophage scavenger receptor 1 (MSR1) gene (NM_138715) was
amplified from HK-2 genomic DNA by PCR using the HotMaster
Taq DNA polymerase (5 PRIME, Gaithersburg, MD), with the
following primers: 50-CATCAGGGATCCATGGAGCAGTGGGATC
ACTTTC-30 (forward) and 50-CATCAGGTTTAAACTTATAAAGT
GCAAGTGACTCCAG-30 (reverse). The 3763-bp PCR product was
cloned between the PmeI and BamHI site of the pCAG-GFP vector
(Addgene plasmid 16664), to generate pCAG-SR-A.
Ox-LDL was a kind gift from Dr Jizhong Chen36 (Baylor College
of Medicine). Dihydrorhodamine-123 and dihydroethidium were
purchased from Invitrogen (Carlsbad, CA); Creatinine Companion
kit and urine albumin ELISA kit were purchased from Exocell
(Philadelphia, PA); malondialdehyde TBARS Assay Kit was pur-
chased from Cell Biolabs (San Diego, CA); RNeasy kit was purchased
from Qiagen (Valencia, CA); MCP-1, TNF-a, and IL-6 ELISA kits
were purchased from Phoenix Pharmaceuticals (Burlingame, CA);
cholesterol CII kit and L-type triglyceride H kit were purchased from
Wako Chemicals (Richmond, VA). All other reagents were purchased
from Sigma-Aldrich unless otherwise noted.
Animal studies
SRA/ mice and their wild-type control have been described
elsewhere.13 To establish a lipid-induced kidney injury model,
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Figure 9 |Renal lipid accumulation, leukocyte filtration, and cytokine expression in BMT uninephrectomized mice at 16 weeks
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analyzed by flow cytometry. (d) Renal cytosolic MCP-1, (e) TNF-a, and (f) IL-6 assayed by enzyme-linked immunosorbent assay. Each bar
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Table 3 |Metabolic data of the BMT mice at 16 weeks of dietary intervention
Normal diet High-fat diet
Groups
WT to WT
(n=6)
WT to SR-A/
(n=6)
SR-A / to WT
(n=7)
WT to WT
(n=6)
WT to SR-A/
(n=6)
SR-A / to WT
(n=5)
Body weight (g) 33.4±3.5 34.2±2.5 34.1±2.5 54.9±3.6a 55.5±3.4b 55.3±4.7c
BP (mmHg) 92.5±10.3 92.7±9.3 92.0±11.5 92.2±10.7 94.2±10.8 93.1±8.9
Plasma Cr (mol/l) 62.5±5.3 66.5±6.4 63.5±4.7 110.4±6.5a 106.0±7.8b 96.2±8.5c,d,e
Plasma triglyceride (mmol/l) 1.33±0.56 1.41±0.61 1.35±0.36 2.55±0.41a 2.58±0.63b 2.54±0.94c
Plasma cholesterol (mmol/l) 2.45±0.48 2.39±0.63 2.49±0.46 6.76±0.93a 6.79±0.69b 6.72±0.76c
Plasma MCP-1 (mg/l) 129.1±9.2 126.1±8.7 128.9±9.7 279.0±10.2a 264.0±11.2b 167.0±10.3c,d,e
Plasma IL-6 (mg/l) 112.5±6.7 108.3±6.9 110.4±6.3 469.9±8.7a 439.1±14.6b 211.2±9.5c,d,e
Plasma TNF-a (mg/l) 73.5±6.9 69.0±7.8 68.5±7.1 159.9±6.8a 174.6±10.1b 99.20±14.6c,d,e
Abbreviations: BMT, bone marrow transplantation; BP, blood pressure; Cr, creatinine; IL-6, interleukin-6; MCP-1, monocyte chemoattractant protein-1; SR-A, scavenger
receptor A; SR-A/, SR-A deficiency mice; TNF-a, tumor necrosis factor-a; WT, SR-A wild-type mice.
aPo0.05 versus WT to WT BMT mice fed with normal diet.
bPo0.05 versus WT to SR-A/ BMT mice fed with normal diet.
cPo0.05 versus SR-A/ to WT BMT mice fed with normal diet.
dPo0.05 versus WT to WT BMT mice fed with high fat diet.
ePo0.05 versus WT to SR-A/ BMT mice fed with high-fat diet.
Data are means±s.e.m.
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B20 g, male, 8-week-old WT and SRA/ mice underwent
uninephrectomy, and were then randomized into four groups:
group 1: WT, normal diet (standard chow containing 270mg
cholesterol per kg); group 2: SR-A/, normal diet; group 3: WT,
high-fat diet (standard chow supplemented with 10% saturation oil
and 1% cholesterol);15,37 and group 4: SR-A/, high-fat diet; 12
animals in each group. Following 16 weeks of diet intervention,
blood and kidneys were harvested for next experiment. All animal
studies were carried out with the review and approval of the animal
care and use committee of Sun Yat-sen University and Baylor
College of Medicine.
Blood biochemical components and blood pressure analysis
Plasma creatinine, MCP-1, TNF-a, IL-6, cholesterol, and triglyceride
were measured using the kits described above according to the
manufacturer’s protocol. Systolic blood pressure was measured
through a tail-cuff apparatus (AD Instruments, Bella Vista,
Australia) in conscious mice. Systolic blood pressure values were
derived from an average of five measurements per animal.
Morphometric studies
With periodic acid–Schiff–stained sections, light microscopic views
of 40 consecutive glomerular cross-sections per mouse were scanned
into a computer. Glomerular and mesangial matrix area were
quantified in a blinded fashion using an image analysis system (NIS
Elements, Nikon, Sendai, Japan). Mesangial matrix index was
calculated as the ratio of mesangial area to tuft area  100 (% area).
The percentage of tubulointerstitial fibrosis area was determined
on Masson’s trichrome-stained sections using a computer-aided
manipulator program as described above. In all, 20 fields of
tubulointerstitial area under low magnification ( 200) per mouse
were scanned to analyze the fibrosis area.
Oil Red O staining
Frozen sections were stained by Oil Red O and quantified as
described with modification.38 Briefly, Oil Red O–positive cells were
counted in at least 20 high-power ( 400) fields with a micro square
scale plate (0.0625mm2) arranged in ocular lens. The number of Oil
Red O–positive cells in kidney was represented as cells/mm2.
Immunohistochemistry and immunoblot analysis
Association of fibrosis protein was assessed by western blot and
immunohistochemistry as described previously.39,40
Lipid extraction and lipid peroxidation determination
Total lipid was extracted from kidneys by the method of Bligh and
Dyer.41 Lipoperoxides in renal tissue were determined by measure-
ment of malondiadehyde–thiobarbituric acid using a kit described
above according to the manufacturer’s protocol.
Determination of ROS
Distribution of superoxide anion in kidney was stained by
dihydroethidium (5 mmol/l) on frozen sections and the intensity
was analyzed at 585 nm with a confocal microscopy. Quantification
of superoxide anion in HK-2 cells was analyzed on the coverslips
stained with dihydrorhodamine-123 (5mmol/l). Fluorescence of the
dihydrorhodamine-123 oxidation product was measured with a
multi-channel analyzer using 490 nm excitation and recording the
fluorescence emission at the optimum (525±3 nm).
Cell culture and plasmid, siRNA transfection
HK-2 cells (human renal proximal tubular epithelial cells) were
cultured as described.42 Cells were grown to confluence and serum-
deprived for 48 h before experimental manipulation. All experi-
ments were performed under serum-free conditions. Under these
conditions, the cells remained viable in a nonproliferation state.
Nonspecific siRNA, SR-A siRNA, pCAG-SR-A, and pNVL3-MnSOD
plasmid were transfected into HK-2 cells using Lipofectamine
2000TM (Invitrogen) at a final concentration of 30 nmol/l.
Flow cytometry
Mice renal cells were prepared as described.43 The following primary
monoclonal antibodies were used for labeling cell suspensions:
monoclonal anti-CD11c (1:100), which recognizes the circulating
cells, and monoclonal anti-CD68 (1:100), which recognize resident
macrophages. Cells at a concentration of 5–10 106 /ml were
incubated with primary antibody in Hank’s balanced salt solution
with 1% fetal calf serum (HBSS-FCS) at 4 1C for 45min. After three
washes in HBSS-FCS, cells were resuspended at the same
concentration and incubated with fluorescein-conjugated second
antibody (Invitrogen) with 1% bovine serum albumin for 30min at
4 1C. The cells were washed twice in HBSS-FCS and finally
suspended at B1 106 cells/ml in protein-free HBSS for flow
cytometry (BD Biosciences) analysis.
BMT protocol
Male WT C57BL/6 (The Jackson Laboratory, Sacramento, CA) and
SR-A/ mice, 8 weeks old, underwent total body lethal irradiation
(9.5 Gy) to eliminate endogenous BM stem cells and circulating
leukocytes. BM cells used for repopulation were extracted from the
femur and tibia of 12 WT and 12 SR-A/ mice. Irradiated mice
were injected intravenously with 107 BM cells from either WT or
SR-A/ mice. At 4 weeks after BMT, blood and leukocyte counts
returned to normal (Table 2). Therefore, uninephrectomized
operation was performed 4 weeks after BMT. All irradiated mice
that were not injected with transplanted BM cells died within 2 to
3 weeks after radiation.
Statistical analyses
Data obtained from this study were expressed as the mean±s.e.m.
Statistical analyses were performed using one-way analysis of
variance followed by Tukey’s multiple comparison test with
GraphPad Prism 5.0 (GraphPad Software, San Diego, CA) to
determine the significance of differences in multiple comparisons.
A P-value of o0.05 was considered statistically significant.
DISCLOSURE
All the authors declared no competing interests.
ACKNOWLEDGMENTS
We are grateful to Dr Wenhua Ling and Dr Ming Xia (Public Health
School, Sun Yat-sen University, Guangzhou, China) for the supply of
SR-A knockout mice. We appreciate Dr Xueqing Yu (The First
Affiliated Hospital, Sun Yat-sen University) and Dr Hiroshi Suzuki
(Obihiro University of Agriculture and Veterinary Medicine, Obihiro,
Japan) for technical support. This work was supported by grants from
the National Natural Science Foundation Committee (30670979) and
Nature Science Foundation Committee of Guangdong Province
(5001206), China.
Kidney International (2012) 81, 1002–1014 1013
W Wang et al.: SR-A and lipid nephrotoxicity o r ig ina l a r t i c l e
SUPPLEMENTARY MATERIAL
Figure S1. Identification of SR-A gene in mice.
Supplementary material is linked to the online version of the paper at
http://www.nature.com/ki
REFERENCES
1. Moorhead JF, Chan MK, El-Nahas M et al. Lipid nephrotoxicity in chronic
progressive glomerular and tubulo-interstitial disease. Lancet 1982; 2:
1309–1311.
2. Ruan XZ, Varghese Z, Moorhead JF. An update on the lipid nephrotoxicity
hypothesis. Nat Rev Nephrol 2009; 5: 713–721.
3. Herzlinger D. Renal interstitial fibrosis: remembrance of things past? J Clin
Invest 2002; 110: 305–306.
4. Trevisan R, Dodesini AR, Lepore G. Lipids and renal disease. J Am Soc
Nephrol 2006; 17: S145–S147.
5. Suzuki H, Kurihara Y, Takeya M et al. The multiple roles of macrophage
scavenger receptors (MSR) in vivo: resistance to atherosclerosis and
susceptibility to infection in MSR knockout mice. J Atheroscler Thromb
1997; 4: 1–11.
6. Okamura DM, Lopez-Guisa JM, Koelsch K et al. Atherogenic scavenger
receptor modulation in the tubulointerstitium in response to chronic
renal injury. Am J Physiol Renal Physiol 2007; 293: F575–F585.
7. Hu C, Kang BY, Megyesi J et al. Deletion of LOX-1 attenuates renal injury
following angiotensin II infusion. Kidney Int 2009; 76: 521–527.
8. Okamura DM, Pennathur S, Pasichnyk K et al. CD36 regulates oxidative
stress and inflammation in hypercholesterolemic CKD. J Am Soc Nephrol
2009; 20: 495–505.
9. Yamamoto N, Toyoda M, Abe M et al. Lectin-like oxidized LDL receptor-1
(LOX-1) expression in the tubulointerstitial area likely plays an important
role in human diabetic nephropathy. Intern Med 2009; 48: 189–194.
10. Grolleau A, Misek DE, Kuick R et al. Inducible expression of macrophage
receptor Marco by dendritic cells following phagocytic uptake of dead cells
uncovered by oligonucleotide arrays. J Immunol 2003; 171: 2879–2888.
11. Babaev VR, Gleaves LA, Carter KJ et al. Reduced atherosclerotic lesions in
mice deficient for total or macrophage-specific expression of scavenger
receptor-A. Arterioscler Thromb Vasc Biol 2000; 20: 2593–2599.
12. Kamada N, Kodama T, Suzuki H. Macrophage scavenger receptor (SR-A I/
II) deficiency reduced diet-induced atherosclerosis in C57BL/6J mice.
J Atheroscler Thromb 2001; 8: 1–6.
13. Suzuki H, Kurihara Y, Takeya M et al. A role for macrophage scavenger
receptors in atherosclerosis and susceptibility to infection. Nature 1997;
386: 292–296.
14. Ruan XZ, Moorhead JF, Fernando R et al. Regulation of lipoprotein
trafficking in the kidney: role of inflammatory mediators and transcription
factors. Biochem Soc Trans 2004; 32: 88–91.
15. Eddy AA. Interstitial inflammation and fibrosis in rats with diet-induced
hypercholesterolemia. Kidney Int 1996; 50: 1139–1149.
16. Kasiske BL, O’Donnell MP, Schmitz PG et al. Renal injury of diet-induced
hypercholesterolemia in rats. Kidney Int 1990; 37: 880–891.
17. Vasconcelos EM, Degasperi GR, de Oliveira HC et al. Reactive oxygen
species generation in peripheral blood monocytes and oxidized LDL are
increased in hyperlipidemic patients. Clin Biochem 2009; 42: 1222–1227.
18. Nielsen F, Mikkelsen BB, Nielsen JB et al. Plasma malondialdehyde as
biomarker for oxidative stress: reference interval and effects of life-style
factors. Clin Chem 1997; 43: 1209–1214.
19. Patsouris D, Li PP, Thapar D et al. Ablation of CD11c-positive cells
normalizes insulin sensitivity in obese insulin resistant animals. Cell Metab
2008; 8: 301–309.
20. Charo IF, Ransohoff RM. The many roles of chemokines and chemokine
receptors in inflammation. New Engl J Med 2006; 354: 610–621.
21. Deshmane SL, Kremlev S, Amini S et al.Monocyte chemoattractant protein-
1 (MCP-1): an overview. J Interferon Cytokine Res 2009; 29: 313–326.
22. Tesch GH, Schwarting A, Kinoshita K et al. Monocyte chemoattractant
protein-1 promotes macrophage-mediated tubular injury, but not
glomerular injury, in nephrotoxic serum nephritis. J Clin Invest 1999; 103:
73–80.
23. Schnaper HW, Hayashida T, Poncelet AC. It’s a Smad world: regulation
of TGF-beta signaling in the kidney. J Am Soc Nephrol 2002; 13:
1126–1128.
24. Wang W, Huang XR, Li AG et al. Signaling mechanism of TGF-beta1 in
prevention of renal inflammation: role of Smad7. J Am Soc Nephrol 2005;
16: 1371–1383.
25. Fiocchi C. TGF-beta/Smad signaling defects in inflammatory bowel
disease: mechanisms and possible novel therapies for chronic
inflammation. J Clin Invest 2001; 108: 523–526.
26. Steinmetz OM, Stahl RA. A new partnership between TGF-beta1 and
glucocorticoids in the network of inflammation. Kidney Int 2003; 63:
2317–2318.
27. Chade AR, Bentley MD, Zhu X et al. Antioxidant intervention prevents
renal neovascularization in hypercholesterolemic pigs. J Am Soc Nephrol
2004; 15: 1816–1825.
28. Iacobini C, Menini S, Ricci C et al. Advanced lipoxidation end-products
mediate lipid-induced glomerular injury: role of receptor-mediated
mechanisms. J Pathol 2009; 218: 360–369.
29. Duffield JS, Tipping PG, Kipari T et al. Conditional ablation of
macrophages halts progression of crescentic glomerulonephritis. Am J
Pathol 2005; 167: 1207–1219.
30. Ye Q, Chen Y, Lei H et al. Inflammatory stress increases unmodified LDL
uptake via LDL receptor: an alternative pathway for macrophage foam-
cell formation. Inflamm Res 2009; 58: 809–818.
31. Utsunomiya K, Ohta H, Kurata H et al. The effect of macrophage colony-
stimulating factor (M-CSF) on the progression of lipid-induced
nephrotoxicity in diabetic nephropathy. J Diabetes Complications 1995; 9:
292–295.
32. Hattori M, Nikolic-Paterson DJ, Miyazaki K et al. Mechanisms of
glomerular macrophage infiltration in lipid-induced renal injury.
Kidney Int Suppl 1999; 71: S47–S50.
33. Nakagawa T, Li JH, Garcia G et al. TGF-beta induces proangiogenic and
antiangiogenic factors via parallel but distinct Smad pathways. Kidney Int
2004; 66: 605–613.
34. Zeisberg M, Hanai J, Sugimoto H et al. BMP-7 counteracts TGF-beta1-
induced epithelial-to- mesenchymal transition and reverses chronic renal
injury. Nat Med 2003; 9: 964–968.
35. Epperly MW, Travis EL, Whitsett JA et al. Overexpression of manganese
superoxide dismutase (MnSOD) in whole lung or alveolar type II cells of
MnSOD transgenic mice does not provide intrinsic lung irradiation
protection. Int J Cancer 2001; 96: 11–21.
36. Chen JZ, Zhang FR, Tao QM et al. Number and activity of endothelial
progenitor cells from peripheral blood in patients with
hypercholesterolaemia. Clin Sci (Lond) 2004; 107: 273–280.
37. Eddy AA. Interstitial fibrosis in hypercholesterolemic rats: role of
oxidation, matrix synthesis, and proteolytic cascades. Kidney Int 1998; 53:
1182–1189.
38. Jiang T, Liebman SE, Lucia MS et al. Role of altered renal lipid
metabolism and the sterol regulatory element binding proteins in
the pathogenesis of age-related renal disease. Kidney Int 2005; 68:
2608–2620.
39. Xiao H, Shi W, Liu S et al. 1,25-Dihydroxyvitamin D(3) prevents puromycin
aminonucleoside- induced apoptosis of glomerular podocytes by
activating the phosphatidylinositol 3-kinase/Akt-signaling pathway.
Am J Nephrol 2009; 30: 34–43.
40. Fu P, Liu F, Su S et al. Signaling mechanism of renal fibrosis in unilateral
ureteral obstructive kidney disease in ROCK1 knockout mice. J Am Soc
Nephrol 2006; 17: 3105–3114.
41. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and
purification. Can J Biochem Physiol 1959; 37: 911–917.
42. Ryan MJ, Johnson G, Kirk J et al. HK-2: an immortalized proximal tubule
epithelial cell line from normal adult human kidney. Kidney Int 1994; 45:
48–57.
43. Cook HT, Smith J, Cattell V. Isolation and characterization of inflammatory
leukocytes from glomeruli in an in situ model of glomerulonephritis in
the rat. Am J Pathol 1987; 126: 126–136.
This work is licensed under the Creative Com-
mons Attribution-NonCommercial-Share Alike
3.0 Unported License. To view a copy of this license, visit
http://creativecommons.org/licenses/by-nc-sa/3.0/
1014 Kidney International (2012) 81, 1002–1014
or ig ina l a r t i c l e W Wang et al.: SR-A and lipid nephrotoxicity
